Objectives: To elucidate the effect of selective endothelin ET -and mixed ET -receptor antagonists on endothelial vasomotor A A / B dysfunction in rats with heart failure after myocardial infarction (MI). Methods: Vasoreactivity and superoxide anion formation were determined in aortic rings from Wistar rats 12 weeks after extensive MI (.46% of left ventricle) compared to sham-operated animals. Rats were either treated with the selective ET -receptor antagonist LU 135252 (30 mg / kg / day), the mixed ET -receptor antagonist
Introduction
Endothelin, the most potent vasoconstrictor substance known, contributes to the increased peripheral resistance in The pathophysiological events following myocardial humans and rats with chronic cardiac dysfunction by infarction (MI) are modulated by the endogenous endoperipheral vasoconstriction [7, 8] . A shift of the balance thelin (ET) system. Development of heart failure is between dilator and constrictor influences may also be accompanied by an altered regulation of the two specific crucial for the development of endothelial dysfunction in ET receptor subtypes characterized so far, the so-called heart failure. Reduced endothelium-dependent vasodilator ET and ET receptor (for review see Ref. [1] ). In capacity of coronary, large conductance and peripheral A B addition, increased plasma ET levels correlate with the arteries contributes to reduced myocardial perfusion, inseverity of heart failure [2] . Long-term treatment with both creased peripheral vascular resistance and cardiac workmixed ET antagonists and selective ET antagonists, load in patients with heart failure and experimental models A / B A partially prevents left ventricular dilation and improves of cardiac dysfunction [9] [10] [11] [12] [13] [14] . Alteration of endothelial hemodynamics and survival in rats with chronic MI [3] [4] [5] [6] .
function has been attributed to a decreased production of endothelium-derived nitric oxide (NO) due to an attenuated expression of the endothelial NO synthase *Corresponding author. Present address: Medizinische Univer-(eNOS) [15] . This may be the result of a chronicallÿs surface [16] . In addition, an increased generation of al left coronary artery. Subsequently, the heart was re-2 superoxide (O ) radicals may reduce the bioavailability of turned to its normal position and the thorax closed. On the 2 NO and contribute to the attenuation of endotheliumseventh postoperative day, surviving rats were randomly dependent dilations in heart failure [17] . selected for ET antagonist or placebo treatment and The endothelium has been recognized as an important maintained with free access to standard rat chow and therapeutic target in heart failure, since the normalization water. Bosentan (100 mg / kg body wt) and LU 135252 (30 of endothelial function reduces vascular resistance and mg / kg body wt) were prepared freshly every day as a enhances arterial compliance, tissue perfusion and exercise microsuspension in 5% arabic gum and administered by capacity [16, 18, 19] . However, the effect of ET-receptor gavage daily for 11 weeks. These doses were chosen since blockade on endothelial dysfunction in chronic ischemic the pressor effect of ET-1 in Wistar rats at various oral heart failure has not been elucidated yet. ET-receptor doses of Bosentan was inhibited following application of a antagonists exert beneficial effects on endothelial function dose of 100 mg / kg body wt [3] . Furthermore, treatment in other cardiovascular diseases such as hypertension (for with LU 135252 at a dose of 30 mg / kg body wt completereview see Ref. [20] endothelium-dependent and -independent dilator as well as 48C and stored at 2808C. The heart was subsequently contractile responses in the aorta from rats with chronic excised and dissected into atria, right, and left ventricle heart failure following experimental MI. Our hypothesis including septum, in ice-cold Krebs-Ringer solution. was that ET antagonists may improve NO-mediated vasoHistological slices (5 mm) were obtained and stained with dilation. In order to elucidate the potential mechanisms, by van Gieson's stain. The boundary length of the infarcted which the ET-antagonists ameliorate the attenuated endoand non-infarcted endocardial and epicardial surfaces were thelium-dependent relaxation in heart failure, we investitraced with a planimeter digital image analyzer. The descending thoracic aorta was dissected following removal of the heart and cleaned of connective tissue. The 2.1. Study protocol, myocardial infarction, hemodynamic lower section (10 mm) was used for measurement of measurements superoxide anion production, while the remainder was cut into rings (3 mm in length) which were mounted in an Left coronary artery ligations were performed in adult organ bath (Fohr Medical Instruments, Seeheim, Germany) male Wistar rats (250-300 g) as previously described [3] .
for isometric force measurement. The rings were equiliBriefly, the thorax was opened under ether anesthesia, the brated for 30 min under a resting tension of 2 g in heart exteriorized and a ligature placed around the proximoxygenated (95% O / 5% CO ) Krebs-Henseleit solution (NaCl 118 mmol / l, KCl 4.7 mmol / l, MgSO 1.2 mmol / l, available from Sigma (Deisenhofen, Germany mmol / l, glucose 12 mmol / l; pH 7.4, 378C) containing the 135252 by Knoll AG (Ludwigshafen, Germany). cyclo-oxygenase inhibitor diclofenac (1 mmol / l) [24] . Rings were repeatedly contracted by KCl (50 mmol / l) 2.7. Statistics until reproducible responses were obtained and a concentration-response curve to phenylephrine (1 nmol / l to Dilator responses were given as percentage dilatation 10 mmol / l) was constructed. Thereafter, the rings were relative to the preconstriction level, constrictions were preconstricted with phenylephrine (0.3-1 mmol / l) to expressed as percentage of the response to KCl. Values are comparable constriction levels and the relaxant response to expressed as mean6S.E.M. of n experiments with segcumulative doses of acetylcholine and to sodium nitroments from different arteries. Statistical analysis was prusside was assessed. In additional experiments the performed by two factor analysis of variance (ANOVA) or relaxant effect of exogenous superoxide dismutase (SOD, one-way ANOVA followed by a Bonferroni t-test or by the 600 U / ml) as well as the effect of SOD (200 U / ml) on two-tailed Student's t-test for unpaired data, where approacetylcholine-induced relaxations was assessed. separate series of experiments we also used a concentration sure in infarcted animals as compared to the placebo of 5 mmol / l and obtained similar results (data not shown).
group. The mixed antagonist Bosentan did not significantly affect hemodynamic parameters, but did reduce left ven-2.5. Plasma endothelin levels and renin activity tricular cavity area, a measure for ventricular dilation, which was only slightly attenuated by LU 135252. Plasma ET-1 levels were determined after reversedphase chromatography (Sep-Pak C-18, Waters Corp.) by a 3.2. Vasoconstrictor responses in aortic rings radioimmunoassay (DuPont NEN) as described [3] .
Plasma renin activity (PRA) was measured by radioimThe tension developed by KCl (50 mmol / l) was similar munoassay of angiotensin I generation (Sorin Biomedica among the various groups (Sham: 1.360.2 g, MI Plac: Diagnostic, Saluggia, Italy) [3] .
1.460.1 g, MI LU 135252: 1.560.2 g, MI Bosentan: 1.560.2 g). Cumulative application of phenylephrine 2.6. Materials elicited a concentration-dependent constriction in aortic rings which was slightly but not significantly increased in All biochemicals were obtained in the highest purity rats with heart failure as compared to sham-operated animals (Fig. 1A) . ET-1-induced constriction was similar in both groups of rats (Fig. 1B) . Furthermore, neither long term-treatment with the ET A antagonist LU 135252 nor with the mixed antagonist Bosentan significantly affected the contractile responses elicited by both agonists (Fig. 1). 
Vasodilator responses in aortic rings
In phenylephrine-preconstricted aortic rings, acetylcholine induced a concentration-dependent relaxation which was blunted in aortae from rats with chronic MI ( Fig. 2A and Table 2 ). The concentration-response curve of the endothelium-independent vasodilator sodium nitroprusside was not different between sham-operated animals and rats with heart failure, although it was slightly shifted to the rings from rats with heart failure ( Fig. 2B and Moreover, the mixed antagonist Bosentan also improved (3.961.0 pg / ml) had a significant effect on plasma ET acetylcholine-induced relaxation in aortic rings from rats levels in rats with heart failure. with chronic MI, however, the dilator response remained slightly diminished as compared to the placebo-treated 3.7. Plasma renin activity sham-operated animals ( Fig. 2C and Table 2 ).
Plasma renin activity (ng angiotensin I ml / h) was almost 3.4. Effects of radical scavengers on vascular reactivity doubled in rats with heart failure (36.563.6) as compared to sham-operated animals (19.963.9; P,0.01). In rats In phenylephrine-preconstricted aortic rings, exogenous with heart failure treated with LU 135252 plasma renin superoxide dismutase (SOD, 600 U / ml) elicited a dilator activity was significantly reduced (19.264.4, P,0.01), response, which was significantly enhanced in aortae from whereas chronic Bosentan treatment did not significantly 2 rats with chronic MI suggesting enhanced O production affect plasma renin activity (28.264.4).
(8363 vs. 5863%, P,0.01). Long term treatment with LU 13525significantly reduced SOD-induced relaxation (6263%, P,0.01).
In contrast, Bosentan had no effect on 4. Discussion SOD-induced relaxation in rats with chronic MI (8363%).
Furthermore we evaluated the effect of exogenous SOD In the present study, we demonstrate the improvement (200 U / ml) on the relaxation elicited by a median of NO-mediated relaxations in rats with heart failure concentration of acetylcholine. In aortae from rats with following MI by chronic treatment with both selective chronic MI treated with placebo acetylcholine-induced ET -and mixed ET -receptor antagonists. While the A A / B relaxation was significantly enhanced in the presence of selective ET antagonist LU 135252 normalized plasma A exogenous SOD, albeit not completely restored as comrenin activity and vascular superoxide anion production, pared to sham-operated animals (Fig. 4) . Although longthe ET blocker Bosentan prevented left ventricular A / B term treatment with both ET-receptor blockers significantly dilation. improved acetylcholine-induced relaxation per se in the Chronic heart failure is associated with endothelial absence of SOD, LU 135252 was more effective (Fig. 4) . dysfunction of coronary and peripheral arteries contributMoreover, only in the Bosentan group, but not in the LU ing to reduced myocardial perfusion, arterial compliance, 135252-treated animals, exogenous SOD further enhanced and elevated peripheral vascular resistance [9] [10] [11] . The the dilator response (Fig. 4) .
underlying mechanisms appear to be complex including an imbalance between dilation and constriction with a pre-3.5. Production of superoxide anions dominance of the contractile stimuli, and a defective production of endothelium-derived NO due to an at-2 O generated by aortic rings was assessed by lucigenintenuated expression of eNOS [15, 25] . We demonstrated 2 2 enhanced chemiluminescence. O release was greater in recently that in rats with ischemic heart failure endothelial 2 aortae from rats with chronic MI (Table 3) and was dysfunction was present despite an augmented eNOS significantly reduced in rats treated with LU 135252 but expression [17] and provided experimental evidence for an not in the Bosentan group.
increased vascular release of superoxide anion. An imbal-2 ance between NO and O production with a reduction of 2 3.6. Plasma endothelin levels bioactive NO despite a normal or even increased generation of NO, has been associated with endothelial dysfunc-ET plasma level was markedly enhanced in rats with tion in other cardiovascular diseases such as hypertension heart failure (3.860.8 pg / ml) as compared to sham-operand atherosclerosis [24, [26] [27] [28] . ated animals (1.360.3 pg / ml, P,0.05). Neither treatment
The effect of chronic treatment with ET antagonists on Our data show that Bosentan had only minor effects on blood pressure in rats with heart failure. In agreement with recent studies Bosentan significantly reduced left ventricular dilation [3, 4] . Improved left ventricular function may enhance blood flow and shear stress at the endothelial surface of the vessels resulting in improvement of endothelial function [16] . In contrast, the ET blocker LU A 135252 significantly reduced blood pressure in rats with heart failure, but elicited only non-significant ameliorations in left ventricular dilation. A lack of effect of an ET A antagonist on cardiac remodeling has also recently been demonstrated in a pig model of pacing-induced heart failure [29] . However, Mulder et al. [6] found a small, albeit significant attenuation of left ventricular dilatation. Differences of results may be explained by the time when active treatment was started. This is supported by recent observations that when given immediately after the infarction procedure, ET -antagonists even aggravated left ven-A tricular dilation [30, 31] . Therefore, the beneficial effects of LU 135252 on endothelium-dependent dilation may not be secondary to a correction of left ventricular function.
As ET-induced constrictions are mediated predominantly by ET receptors on vascular smooth muscle cells and modulate the sensitivity to contractile agonists. However, we did not observe a significant increase in phenylephrinemediated contractions in rats with heart failure. Furthermore, neither LU 135252 nor Bosentan treatment significantly affected the phenylephrine-and ET-induced contractions in the aorta from rats with heart failure. Although both ET antagonists improved endotheliumdependent relaxation, a considerable difference between mixed ET and selective ET blockers consisted in their A contrasting effects on aortic superoxide production. While hypertension and chronic NO-deficient hypertension, patients and is a useful model for novel therapies [34, 35] . mixed ET antagonists were not effective whereas Furthermore, the endothelium has been recognized as a
selective ET -receptor blockade improved vascular dilator therapeutic target in heart failure, since beneficial modula-A responses [21] [22] [23] (for review see Ref. [20] ). Although the tion of endothelial function will reduce vascular resistance underlying mechanisms are not clear, in rats with heart and enhance arterial compliance and tissue perfusion failure treatment with LU 135252 decreased plasma renin [16, 18, 19] .These assumptions are supported by recent activity, an index of the stimulation of the renin-angiotenfindings which suggest that in patients with heart failure sin system, whereas Bosentan had no effect. As angiotenimproved endothelial function results in enhanced exercise sin II constitutes an important stimulus for vascular radical capacity [16, 36] . Due to the heterogeneity of vascular generation [28, 32] , the normalization of renin activity by reactivity over the arterial bed, our results obtained in the ET antagonist but not by Bosentan may lead to the aortic rings cannot be easily extrapolated to other arteries The improvement of endothelial vasodilator function by more clinical benefit. ET receptor blockade in heart failure may be of consider-
In conclusion, our data show that long-term treatment able clinical relevance. Heart failure after extensive MI in with ET antagonists improves NO-mediated dilation in rats the rat closely mimics the pathophysiological situation in with chronic MI. This mechanism may play an important role for beneficial effects of these drugs in heart failure. Selective ET blockade markedly attenuates the activation 
